Chester S Zygmont III's Stock Transactions in Revelation Biosciences, Inc.

On October 29, 2025, Chester S Zygmont III, the Chief Financial Officer of Revelation Biosciences, Inc., acquired 390,614 shares of common stock at a price of $1.28 per share. This transaction was part of a restricted stock grant under the 2021 Equity Incentive Plan, which vests quarterly over one year from the date of grant. Following this transaction, Zygmont's total holdings in the company increased to 395,645 shares. Additionally, Zygmont holds 5,026 shares through The Zygmont Family Trust and 5 shares through Czeslaw Capital Fund, LLC, where he serves as the sole manager. The filing also includes footnotes detailing the nature of these holdings and the specific terms of the stock grant.